Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from epithelial cells of the vermiform appendix
Biomarker and diagnostic research for appendix carcinoma has been reported in the published literature.
20 clinical trials registered, 5 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 1 PHASE3, 3 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05969860](https://clinicaltrials.gov/study/NCT05969860) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:39 AM UTC
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
PHASE2 |
Mayo Clinic |
RECRUITING |
[NCT06715839](https://clinicaltrials.gov/study/NCT06715839) | Target-specific immunoPET Imaging of Digestive System Carcinoma | NA | RenJi Hospital | RECRUITING |
[NCT05780684](https://clinicaltrials.gov/study/NCT05780684) | Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer | NA | Dartmouth-Hitchcock Medical Center | RECRUITING |
[NCT07283939](https://clinicaltrials.gov/study/NCT07283939) | Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays | NA | Alliance for Clinical Trials in Oncology | RECRUITING |
[NCT04907643](https://clinicaltrials.gov/study/NCT04907643) | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | NA | Cedars-Sinai Medical Center | RECRUITING |
144 publications have been identified in PubMed for appendix carcinoma. Research spans Review / Meta-Analysis (42%), Clinical Trial Publication (19%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 60 | 42% |
Clinical study results | 28 | 19% |
Disease patterns and progression | 24 | 17% |
Testing and diagnosis research | 10 | 7% |
Patient case studies | 7 | 5% |
Other research | 6 | 4% |
Laboratory research | 6 | 4% |
New treatment approaches | 3 | 2% |
Zoref-Lorenz A (2026). [PMID: 41337692](https://pubmed.ncbi.nlm.nih.gov/41337692/). *Blood Adv*. [Case Report / Case Series]
Valtis YK (2026). [PMID: 41052404](https://pubmed.ncbi.nlm.nih.gov/41052404/). *Blood Adv*. [Clinical Trial Publication]
Pattalachinti VK (2026). [PMID: 42081241](https://pubmed.ncbi.nlm.nih.gov/42081241/). *JAMA Netw Open*. [Clinical Trial Publication]
Baron E (2026). [PMID: 41317532](https://pubmed.ncbi.nlm.nih.gov/41317532/). *Eur J Surg Oncol*. [Clinical Trial Publication]
Kovalik V (2026). [PMID: 41428018](https://pubmed.ncbi.nlm.nih.gov/41428018/). *Ann Surg Oncol*. [Clinical Trial Publication]
Cayla S (2026). [PMID: 40966637](https://pubmed.ncbi.nlm.nih.gov/40966637/). *Blood Adv*. [Epidemiology / Natural History]
GBD 2021 AEMT Collaborators (2026). [PMID: 41850226](https://pubmed.ncbi.nlm.nih.gov/41850226/). *Korean J Intern Med*. [Epidemiology / Natural History]
Taplin ME (2026). [PMID: 41557978](https://pubmed.ncbi.nlm.nih.gov/41557978/). *J Clin Oncol*. [Review / Meta-Analysis]
Banerjee R (2026). [PMID: 42160714](https://pubmed.ncbi.nlm.nih.gov/42160714/). *J Clin Oncol*. [Review / Meta-Analysis]
Miller RM (2026). [PMID: 42057320](https://pubmed.ncbi.nlm.nih.gov/42057320/). *J Surg Oncol*. [Clinical Trial Publication]